These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer. Calabresi L; Canavesi M; Bernini F; Franceschini G Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455 [TBL] [Abstract][Full Text] [Related]
43. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326 [TBL] [Abstract][Full Text] [Related]
44. Lipid transfer proteins, hypertriglyceridemia, and reduced high-density lipoprotein cholesterol. Sparks D; Frohlich JJ; Pritchard PH Am Heart J; 1991 Aug; 122(2):601-7. PubMed ID: 1858655 [No Abstract] [Full Text] [Related]
45. Hydrolysis of phosphatidylcholine by hepatic lipase in discoidal and spheroidal recombinant high-density lipoprotein. Tansey JT; Thuren TY; Jerome WG; Hantgan RR; Grant K; Waite M Biochemistry; 1997 Oct; 36(40):12227-34. PubMed ID: 9315860 [TBL] [Abstract][Full Text] [Related]
46. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Tan KC; Shiu SW; Pang RW; Kung AW Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231 [TBL] [Abstract][Full Text] [Related]
47. Cholesteryl ester transfer protein and atherosclerosis. Inazu A; Koizumi J; Mabuchi H Curr Opin Lipidol; 2000 Aug; 11(4):389-96. PubMed ID: 10945721 [TBL] [Abstract][Full Text] [Related]
48. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656 [TBL] [Abstract][Full Text] [Related]
49. Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes. Chung BH; Franklin F; Cho BH; Segrest JP; Hart K; Darnell BE Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1217-30. PubMed ID: 9714128 [TBL] [Abstract][Full Text] [Related]
50. [Molecular biology of reverse cholesterol transport system and impairment of the protection system against atherosclerosis]. Yamashita S; Matsuzawa Y Nihon Rinsho; 1993 Jun; 51(6):1684-91. PubMed ID: 8320848 [TBL] [Abstract][Full Text] [Related]
51. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Breslow JL Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8314-8. PubMed ID: 8378301 [TBL] [Abstract][Full Text] [Related]
52. [Cholesterol ester transfer protein. A major player in cholesterol metabolism]. Hansen PR Ugeskr Laeger; 1999 Sep; 161(38):5295-8. PubMed ID: 10536513 [TBL] [Abstract][Full Text] [Related]
53. Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport. Roheim PS Am J Cardiol; 1986 Feb; 57(5):3C-10C. PubMed ID: 3511664 [TBL] [Abstract][Full Text] [Related]
54. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Yamashita S; Hirano K; Sakai N; Matsuzawa Y Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094 [TBL] [Abstract][Full Text] [Related]
55. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans. Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687 [TBL] [Abstract][Full Text] [Related]
56. Lipases and HDL metabolism. Jin W; Marchadier D; Rader DJ Trends Endocrinol Metab; 2002; 13(4):174-8. PubMed ID: 11943562 [TBL] [Abstract][Full Text] [Related]
57. Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability. Rosales C; Gillard BK; Xu B; Gotto AM; Pownall HJ Methodist Debakey Cardiovasc J; 2019; 15(1):47-54. PubMed ID: 31049149 [TBL] [Abstract][Full Text] [Related]
58. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Major AS; Dove DE; Ishiguro H; Su YR; Brown AM; Liu L; Carter KJ; Linton MF; Fazio S Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1790-5. PubMed ID: 11701467 [TBL] [Abstract][Full Text] [Related]